Trial Profile
A prospective study of bevacizumab in progressive/recurrent glioblastoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 23 Aug 2016 New trial record